New hope for Hard-to-Treat myeloma: antibody drug shows promise in japanese patients

NCT ID NCT04696809

First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 26 times

Summary

This study tests a new drug called teclistamab in about 40 Japanese patients whose multiple myeloma has come back or stopped responding to other treatments. The drug is a special antibody that helps the immune system attack cancer cells. The goal is to see if it is safe and how well it works at shrinking the cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Japanese Red Cross Medical Center

    Shibuya City, 150-8935, Japan

  • Japanese Red Cross Osaka Hospital

    Osaka, 543-8555, Japan

  • Kameda Medical Center

    Chiba, 296-8602, Japan

  • Kobe City Medical Center General Hospital

    Kobe, 650 0047, Japan

  • Kurume University Hospital

    Kurume, 830-0011, Japan

  • Kyoto Kuramaguchi Medical Center

    Kyoto, 603-8151, Japan

  • Nagoya City University Hospital

    Nagoya, 467 8602, Japan

  • National Hospital Organization Hiroshima-Nishi Medical Center

    Ōtake, 739-0696, Japan

  • National Hospital Organization Kumamoto Medical Center

    Kumamoto, 860-0008, Japan

  • National Hospital Organization Matsumoto Medical Center

    Matsumoto, 399-8701, Japan

  • National Hospital Organization Mito Medical Center

    Higashiibaraki-gun, 311-3193, Japan

  • National Hospital Organization Okayama Medical Center

    Okayama, 701-1192, Japan

  • Niigata Cancer Center Hospital

    Niigata, 951-8566, Japan

  • Ogaki Municipal Hospital

    Gifu, 503-8502, Japan

  • Osaka International Cancer Institute

    Osaka, 541 8567, Japan

Conditions

Explore the condition pages connected to this study.